H

HLB Life Science Co Ltd
KOSDAQ:067630

Watchlist Manager
HLB Life Science Co Ltd
KOSDAQ:067630
Watchlist
Price: 10 650 KRW 0.28% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
HLB Life Science Co Ltd?
Write Note

HLB Life Science Co Ltd
Investor Relations

HLB Life Sciences Co., Ltd. engages in the provision of energy saving services. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2008-11-25. Along with subsidiaries, the Company operates its business through four segments. The Pharmaceutical Distribution segment is involved in the sale of pharmaceuticals and raw materials through SHINWHAADVANCE.CO.LTD. The Energy Business segment is engaged in energy service company (ESCO) business. The company is equipped with equipments, assets and technical personnel to engage in energy saving investment business. The Bio Development segment is engaged in the development of extracorporeal circulation type bio space, hepatocyte treatment agents and hemostatic agents. The main products include anticancer drugs such as Tegatrabetan and Seclidemstat. The Other Business segment is involved in the investment of small business start-ups and venture businesses, as well as manufacturing and sale of light emitting diode (LED) products.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

No Earnings Calls Available

Management

Sung-Bo Sim
Chief Exec. Officer and Pres
No Bio Available

Contacts

Address
GYEONGGI-DO
Hwaseong
8F, M Tower Knowledge Industry Center, 51-9, Dongtancheomdansaneop 1-ro
Contacts
+82226276700
www.hlb-ls.com